MeSH Browser

MeSH Heading: Gangliosidoses
Tree Number(s): C10.228.140.163.100.435.825.300; C16.320.565.189.435.825.300; C16.320.565.398.641.803.350; C16.320.565.595.554.825.300; C18.452.132.100.435.825.300; C18.452.584.563.641.803.350; C18.452.648.189.435.825.300; C18.452.648.398.641.803.350; C18.452.648.595.554.825.300
Unique ID: D005733
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D005733
Annotation: coordinate IM with specific ganglioside (IM) but GANGLIOSIDOSIS, GM1 and GANGLIOSIDOSES, GM2 are available
Scope Note: A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.
Entry Term(s): Ganglioside Storage Diseases; Ganglioside Storage Disorders; Gangliosidosis
Previous Indexing: Gangliosides (1966-1975); Lipoidosis (1966-1975)
See Also: Mucolipidoses
Public MeSH Note: 1992; see GANGLIOSIDOSIS 1976-91
History Note: 1992(1976)
Date Established: 1976/01/01
Date of Entry: 1975/07/23
Revision Date: 2021/07/01

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Nervous System Diseases [C10]
- Central Nervous System Diseases [C10.228]
  - Brain Diseases [C10.228.140]
    - Brain Diseases, Metabolic [C10.228.140.163]
      - Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]
        
        Lysosomal Storage Diseases, Nervous System [C10.228.140.163.100.435]
        
        Sphingolipidoses [C10.228.140.163.100.435.825]
        
        Fabry Disease [C10.228.140.163.100.435.825.200]
        
        Farber Lipogranulomatosis [C10.228.140.163.100.435.825.250]
        
        Gangliosidoses [C10.228.140.163.100.435.825.300]
        
        Gangliosidoses, GM2 [C10.228.140.163.100.435.825.300.300]
        
        Gangliosidosis, GM1 [C10.228.140.163.100.435.825.300.400]
        
        Gaucher Disease [C10.228.140.163.100.435.825.400]
        
        Leukodystrophy, Globoid Cell [C10.228.140.163.100.435.825.590]
        
        Niemann-Pick Diseases [C10.228.140.163.100.435.825.700]
        
        Sea-Blue Histiocyte Syndrome [C10.228.140.163.100.435.825.775]
        
        Sulfatidosis [C10.228.140.163.100.435.825.850]

Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
  - Metabolism, Inborn Errors [C16.320.565]
    - Brain Diseases, Metabolic, Inborn [C16.320.565.189]
      - Lysosomal Storage Diseases, Nervous System [C16.320.565.189.435]
        
        Sphingolipidoses [C16.320.565.189.435.825]
        
        Fabry Disease [C16.320.565.189.435.825.200]
        
        Farber Lipogranulomatosis [C16.320.565.189.435.825.250]
        
        Gangliosidoses [C16.320.565.189.435.825.300]
        
        Gangliosidoses, GM2 [C16.320.565.189.435.825.300.300]
        
        Gangliosidosis, GM1 [C16.320.565.189.435.825.300.400]
        
        Gaucher Disease [C16.320.565.189.435.825.400]
        
        Leukodystrophy, Globoid Cell [C16.320.565.189.435.825.590]
        
        Niemann-Pick Diseases [C16.320.565.189.435.825.700]
        
        Sea-Blue Histiocyte Syndrome [C16.320.565.189.435.825.775]
        
        Sulfatidosis [C16.320.565.189.435.825.850]

Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
  - Metabolism, Inborn Errors [C16.320.565]
    - Lipid Metabolism, Inborn Errors [C16.320.565.398]
      - Lipidoses [C16.320.565.398.641]
        
        Sphingolipidoses [C16.320.565.398.641.803]
        
        Fabry Disease [C16.320.565.398.641.803.300]
        
        Farber Lipogranulomatosis [C16.320.565.398.641.803.325]
        
        Gangliosidoses [C16.320.565.398.641.803.350]
        
        Gangliosidoses, GM2 [C16.320.565.398.641.803.350.300]
        
        Gangliosidosis, GM1 [C16.320.565.398.641.803.350.360]
        
        Gaucher Disease [C16.320.565.398.641.803.441]
        
        Leukodystrophy, Globoid Cell [C16.320.565.398.641.803.585]
        
        Niemann-Pick Diseases [C16.320.565.398.641.803.730]
        
        Sea-Blue Histiocyte Syndrome [C16.320.565.398.641.803.850]
        
        Sulfatidosis [C16.320.565.398.641.803.925]

Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
  - Metabolism, Inborn Errors [C16.320.565]
    - Lysosomal Storage Diseases [C16.320.565.595]
      - Lysosomal Storage Diseases, Nervous System [C16.320.565.595.554]
        
        Sphingolipidoses [C16.320.565.595.554.825]
        
        Fabry Disease [C16.320.565.595.554.825.200]
        
        Farber Lipogranulomatosis [C16.320.565.595.554.825.250]
        
        Gangliosidoses [C16.320.565.595.554.825.300]
        
        Gangliosidoses, GM2 [C16.320.565.595.554.825.300.300]
        
        Gangliosidosis, GM1 [C16.320.565.595.554.825.300.400]
        
        Gaucher Disease [C16.320.565.595.554.825.400]
        
        Leukodystrophy, Globoid Cell [C16.320.565.595.554.825.590]
        
        Niemann-Pick Diseases [C16.320.565.595.554.825.700]
        
        Sea-Blue Histiocyte Syndrome [C16.320.565.595.554.825.775]
        
        Sulfatidosis [C16.320.565.595.554.825.850]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Brain Diseases, Metabolic [C18.452.132]
    - Brain Diseases, Metabolic, Inborn [C18.452.132.100]
      - Lysosomal Storage Diseases, Nervous System [C18.452.132.100.435]
        
        Sphingolipidoses [C18.452.132.100.435.825]
        
        Fabry Disease [C18.452.132.100.435.825.200]
        
        Farber Lipogranulomatosis [C18.452.132.100.435.825.250]
        
        Gangliosidoses [C18.452.132.100.435.825.300]
        
        Gangliosidoses, GM2 [C18.452.132.100.435.825.300.300]
        
        Gangliosidosis, GM1 [C18.452.132.100.435.825.300.400]
        
        Gaucher Disease [C18.452.132.100.435.825.400]
        
        Leukodystrophy, Globoid Cell [C18.452.132.100.435.825.590]
        
        Niemann-Pick Diseases [C18.452.132.100.435.825.700]
        
        Sea-Blue Histiocyte Syndrome [C18.452.132.100.435.825.775]
        
        Sulfatidosis [C18.452.132.100.435.825.850]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Lipid Metabolism Disorders [C18.452.584]
    - Lipid Metabolism, Inborn Errors [C18.452.584.563]
      - Lipidoses [C18.452.584.563.641]
        
        Sphingolipidoses [C18.452.584.563.641.803]
        
        Fabry Disease [C18.452.584.563.641.803.300]
        
        Farber Lipogranulomatosis [C18.452.584.563.641.803.325]
        
        Gangliosidoses [C18.452.584.563.641.803.350]
        
        Gangliosidoses, GM2 [C18.452.584.563.641.803.350.300]
        
        Gangliosidosis, GM1 [C18.452.584.563.641.803.350.360]
        
        Gaucher Disease [C18.452.584.563.641.803.441]
        
        Leukodystrophy, Globoid Cell [C18.452.584.563.641.803.585]
        
        Niemann-Pick Diseases [C18.452.584.563.641.803.730]
        
        Sea-Blue Histiocyte Syndrome [C18.452.584.563.641.803.850]
        
        Sulfatidosis [C18.452.584.563.641.803.925]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Metabolism, Inborn Errors [C18.452.648]
    - Brain Diseases, Metabolic, Inborn [C18.452.648.189]
      - Lysosomal Storage Diseases, Nervous System [C18.452.648.189.435]
        
        Sphingolipidoses [C18.452.648.189.435.825]
        
        Fabry Disease [C18.452.648.189.435.825.200]
        
        Farber Lipogranulomatosis [C18.452.648.189.435.825.250]
        
        Gangliosidoses [C18.452.648.189.435.825.300]
        
        Gangliosidoses, GM2 [C18.452.648.189.435.825.300.300]
        
        Gangliosidosis, GM1 [C18.452.648.189.435.825.300.400]
        
        Gaucher Disease [C18.452.648.189.435.825.400]
        
        Leukodystrophy, Globoid Cell [C18.452.648.189.435.825.590]
        
        Niemann-Pick Diseases [C18.452.648.189.435.825.700]
        
        Sea-Blue Histiocyte Syndrome [C18.452.648.189.435.825.775]
        
        Sulfatidosis [C18.452.648.189.435.825.850]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Metabolism, Inborn Errors [C18.452.648]
    - Lipid Metabolism, Inborn Errors [C18.452.648.398]
      - Lipidoses [C18.452.648.398.641]
        
        Sphingolipidoses [C18.452.648.398.641.803]
        
        Fabry Disease [C18.452.648.398.641.803.300]
        
        Farber Lipogranulomatosis [C18.452.648.398.641.803.325]
        
        Gangliosidoses [C18.452.648.398.641.803.350]
        
        Gangliosidoses, GM2 [C18.452.648.398.641.803.350.300]
        
        Gangliosidosis, GM1 [C18.452.648.398.641.803.350.360]
        
        Gaucher Disease [C18.452.648.398.641.803.441]
        
        Leukodystrophy, Globoid Cell [C18.452.648.398.641.803.585]
        
        Niemann-Pick Diseases [C18.452.648.398.641.803.730]
        
        Sea-Blue Histiocyte Syndrome [C18.452.648.398.641.803.850]
        
        Sulfatidosis [C18.452.648.398.641.803.925]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Metabolism, Inborn Errors [C18.452.648]
    - Lysosomal Storage Diseases [C18.452.648.595]
      - Lysosomal Storage Diseases, Nervous System [C18.452.648.595.554]
        
        Sphingolipidoses [C18.452.648.595.554.825]
        
        Fabry Disease [C18.452.648.595.554.825.200]
        
        Farber Lipogranulomatosis [C18.452.648.595.554.825.250]
        
        Gangliosidoses [C18.452.648.595.554.825.300]
        
        Gangliosidoses, GM2 [C18.452.648.595.554.825.300.300]
        
        Gangliosidosis, GM1 [C18.452.648.595.554.825.300.400]
        
        Gaucher Disease [C18.452.648.595.554.825.400]
        
        Leukodystrophy, Globoid Cell [C18.452.648.595.554.825.590]
        
        Niemann-Pick Diseases [C18.452.648.595.554.825.700]
        
        Sea-Blue Histiocyte Syndrome [C18.452.648.595.554.825.775]
        
        Sulfatidosis [C18.452.648.595.554.825.850]

Gangliosidoses Preferred

Concept UI: M0008988
Scope Note: A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.
Terms: Gangliosidoses Preferred Term
Term UI T017315
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1976); Gangliosidosis
Term UI T017314
Date09/12/1990
LexicalTag NON
ThesaurusID NLM (1992); Ganglioside Storage Diseases
Term UI T368283
Date11/03/1999
LexicalTag NON
ThesaurusID NLM (2000); Ganglioside Storage Disorders
Term UI T368284
Date11/03/1999
LexicalTag NON
ThesaurusID NLM (2000)

Gangliosidoses MeSH Descriptor Data 2025